查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1792479

心臟假体设备市场报告（依产品类型（瓣膜、心律调节器、植入式心律调节器、体外心律调节器等）、最终用户（医院、诊所和心臟中心、门诊手术中心等）和地区）2025 年至 2033 年）

Cardiac Prosthetic Devices Market Report by Product Type (Valves, Pacemakers, Implantable Pacemakers, External Pacemakers, and Others), End-User (Hospitals, Clinics and Cardiac Centers, Ambulatory Surgical Centers, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球心臟假体设备市场规模达72亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到129亿美元，2025-2033年期间的复合年增长率（CAGR）为6.42%。紧凑型起搏器和无缝线瓣膜置换术的发展、人们对微创(MI)手术的日益青睐以及心血管疾病在人群中的患病率不断上升，是推动市场发展的主要因素。

心臟假体是指用于替代或辅助心臟正常功能的人工装置或植入物。它们用于治疗各种心臟疾病，例如心臟衰竭、瓣膜疾病或先天性心臟缺陷。它们大致可分为两类：人工心臟瓣膜和机械循环支撑装置。人工心臟瓣膜用于替换受损或患病的心臟瓣膜，恢復心臟的正常血流。另一方面，机械循环支持装置用于辅助或替代心臟的泵血功能，通常用作心臟移植前的过渡治疗，或作为不适合心臟移植患者的长期解决方案。此外，它们采用生物相容性材料製成，并经过精心设计，以复製心臟的结构和功能，从而改善患者的心臟功能和生活品质。

全球人口老化是推动该产业发展的因素。随着人口老化，心血管疾病的发生率不断上升，导致对心臟人工装置的需求不断增加。此外，医疗技术和外科手术技术的不断进步提高了心血管疾病患者的存活率，也为这些装置创造了更大的患者群体。同时，大众对心血管健康的认识不断提高，以及治疗方案的可近性也推动了产品需求。此外，患者正在寻求及时的干预措施，包括使用心臟人工装置，以改善生活品质并延长生存期，这对市场产生了积极的影响。其他因素，包括医疗保健行业的持续发展以及主要参与者进行的广泛研发活动，也对市场产生了积极的影响。

心臟假体设备市场趋势/驱动因素：

心血管疾病盛行率及认知度不断提高

心血管疾病，包括冠状动脉疾病、心臟衰竭和心臟瓣膜疾病，是全球发病率和死亡率的重要因素。此外，人们对心臟病的认识不断提高，预防措施也更加完善，治疗方案也更加丰富，使得心血管疾病能够更早发现和诊断。诊断能力的提升，包括超音波心动图和心臟磁振造影等先进的影像技术，有助于准确诊断和识别可能受益于心臟假体的患者。公众意识的提高以及众多疾病盛行率的上升，共同导致了产品需求的不断增长。随着越来越多的人在早期阶段被诊断出患有心血管疾病，越来越多的患者有望从心臟假体介入治疗中受益。

优惠报销政策的实施

报销在心臟假体装置的推广中起着至关重要的作用。政府医疗体系和私人保险公司提供的优惠报销政策，激励医疗机构提供这些设备和治疗方案给病人。这为市场成长创造了有利的环境，因为它降低了患者的经济障碍，并促进了心臟假体装置的使用。此外，日益加重的疾病负担和医疗技术的进步正在增加全球的医疗保健支出。医疗保健支出的增加有助于提高心臟假体装置的可负担性和可近性，使其更容易被有需要的患者获得。此外，市场参与者正在建立合作伙伴关係、合作关係和分销网络，这也是另一个促进成长的因素。

心臟外科手术技术和设备的持续技术创新

心臟外科技术（例如微创手术、机器人辅助手术和经导管介入）的不断进步，扩大了各种心臟疾病的治疗范围。这些进步提高了产品的利用率，包括心臟瓣膜、心室辅助装置 (VAD) 和起搏器，因为它们在这些手术中发挥着至关重要的作用。科技的快速进步彻底改变了心臟假体装置的设计和功能。例如，经导管心臟瓣膜的开发使得微创瓣膜置换手术成为可能，减少了患者的创伤并缩短了復原时间。此外，起搏器和植入式心律转復除颤器 (ICD) 中无线连接、远端监控功能和先进感测器的集成，改善了患者护理和预后，创造了积极的市场前景。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球心臟假体设备市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品类型

  • 阀门
    • 主要类型
      • 机械阀
      • 组织瓣膜
      • 支架组织瓣膜
      • 无支架组织瓣膜
      • 经导管瓣膜
  • 起搏器
  • 植入式心律调节器
    • 主要类型
      • 单腔电池起搏器
      • 双腔电池起搏器
      • 三腔电池起搏器
  • 体外心律调节器
  • 其他的

第七章：市场区隔：依最终用户

  • 医院、诊所和心臟中心
  • 门诊手术中心
  • 其他的

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第九章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Biotronik
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • Lepu Medical Technology Co. Ltd.
    • Medtronic Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Siemens Healthcare GmbH
    • Sorin Group
    • St. Jude Medical Inc.
Product Code: SR112025A2037

The global cardiac prosthetic devices market size reached USD 7.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.42% during 2025-2033. The development of compact pacemakers and suture-less valve replacements, the growing inclination toward minimally invasive (MI) procedures, and the rising prevalence of cardiovascular disorders among the masses are some of the major factors propelling the market.

Cardiac prosthetic devices refer to artificial devices or implants designed to replace or assist the normal functioning of the heart. They are used in the treatment of various heart conditions, such as heart failure, valve disorders, or congenital heart defects. They can be broadly categorized into two types, artificial heart valves and mechanical circulatory support devices. Artificial heart valves are used to replace damaged or diseased heart valves, restoring normal blood flow through the heart. On the other hand, mechanical circulatory support devices are used to assist or replace the pumping function of the heart, often employed as a bridge to transplantation or as a long-term solution for patients ineligible for heart transplantation. Additionally, they are manufactured of biocompatible materials and are meticulously designed to replicate the structure and function of the heart, thereby improving the patient's cardiac function and quality of life.

The industry is driven by the aging global population. As the population continues to age, the incidence of cardiovascular diseases increases, leading to a higher demand for cardiac prosthetic devices. Additionally, continual advancements in medical technology and surgical techniques have improved the survival rates of patients with cardiovascular diseases, this is creating a larger patient pool for these devices. Along with this, the increasing awareness about cardiovascular health and the availability of treatment options among the masses is fueling the product demand. Also, patients are seeking timely interventions, including the use of cardiac prosthetic devices, to improve their quality of life and prolong survival, which is positively influencing the market. Other factors, including continual developments in the healthcare sector and extensive research and development (R&D) activities conducted by key players, are also positively influencing the market.

Cardiac Prosthetic Devices Market Trends/Drivers:

Increasing Prevalence of Cardiovascular Diseases and their Awareness

Cardiovascular diseases, including coronary artery disease, heart failure, and valvular heart diseases, are significant contributors to morbidity and mortality across the globe. Additionally, the increasing awareness about heart diseases, preventive measures, and the availability of treatment options has led to earlier detection and diagnosis of cardiovascular conditions. Improved diagnostic capabilities, including advanced imaging techniques, such as echocardiography and cardiac MRI, facilitate accurate diagnosis and identification of patients who may benefit from cardiac prosthetic devices. The combination of public awareness and the rising prevalence of numerous diseases has led to an increasing product demand. As more individuals are diagnosed with CVDs at an earlier stage, there is a growing pool of patients who could benefit from interventions involving cardiac prosthetics.

The Implementation of Favorable Reimbursement Policies

Reimbursement plays a vital role in the adoption of cardiac prosthetic devices. Favorable reimbursement policies offered by government healthcare systems and private insurance providers incentivize healthcare providers to offer these devices and procedures to their patients. This creates a conducive environment for market growth, as it reduces financial barriers for patients and promotes the use of cardiac prosthetic devices. In addition, the rising disease burden, and advances in medical technology are increasing healthcare expenditure across the globe. This higher healthcare spending is contributing to the affordability and accessibility of cardiac prosthetic devices, making them more widely available to patients in need. Besides this, market players are establishing partnerships, collaborations, and distribution networks, which are acting as another growth-inducing factor.

Continual Technological Innovations in Cardiac Surgery Techniques and Devices

Continuous advancements in cardiac surgical techniques, such as minimally invasive procedures, robotic-assisted surgeries, and transcatheter interventions, have expanded the scope of treating various cardiac conditions. These advancements have increased product utilization, including heart valves, ventricular assist devices (VADs), and pacemakers, as they play a crucial role in these procedures. Rapid advancements in technology have revolutionized the design and functionality of cardiac prosthetic devices. For instance, the development of transcatheter heart valves has enabled less invasive valve replacement procedures, reducing patient trauma and recovery time. Additionally, the integration of wireless connectivity, remote monitoring capabilities, and advanced sensors in pacemakers and implantable cardioverter-defibrillators (ICDs) has improved patient care and outcomes, creating a positive market outlook.

Cardiac Prosthetic Devices Industry Segmentation:

Breakup by Product Type:

  • Valves
    • Mechanical Valve
    • Tissue Valve
    • Stented Tissue Valve
    • Stentless Tissue Valve
    • Transcatheter Valve
  • Pacemakers
  • Implantable Pacemakers
    • Single-Chamber Battery Pacemaker
    • Dual-Chamber Battery Pacemaker
    • Triple-Chamber Battery Pacemaker
  • External Pacemakers
  • Others

Valves dominate the market

Continual technological advancements in valve design and materials have improved the durability, functionality, and overall performance of devices, leading to greater acceptance and adoption. Additionally, the increasing focus on minimally invasive procedures and the development of transcatheter heart valve replacement techniques are positively influencing the demand for valve products.

Additionally, continuous advancements in medical technology have led to the development of innovative pacemaker devices with improved features and functionalities, including wireless connectivity and remote monitoring capabilities, which further drive market growth. Moreover, the rising prevalence of lifestyle-related diseases, such as obesity and diabetes, which are risk factors for heart ailments, is fueling the demand for pacemakers across the globe.

Breakup by End-User:

  • Hospitals, Clinics and Cardiac Centers
  • Ambulatory Surgical Centers
  • Others

Hospitals, clinics and cardiac centers hold the largest share in the market

The increasing usage of these devices in hospitals, clinics, and cardiac centers can be attributed to the continual advancements in medical technology and surgical techniques. The continuous development of innovative devices, such as artificial heart valves and implantable pacemakers, enables healthcare providers to offer improved treatment options to patients. Furthermore, various government initiatives and healthcare reforms aimed at enhancing cardiovascular care and improving patient outcomes also serve as major market drivers for the end-users in the industry.

On the contrary, ambulatory surgical centers (ASCs) as end-users in the cardiac offer numerous advantages, such as cost-effectiveness, convenience, and reduced hospital stays, which are particularly appealing to patients seeking cardiac procedures. These centers provide a suitable environment for minimally invasive surgeries and outpatient treatments, aligning with the growing trend towards value-based healthcare. Additionally, advancements in technology have made it feasible to perform complex cardiac procedures in ASCs, further fueling the market demand in this segment over the forecast period.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest the cardiac prosthetic devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The market in North America is driven by the increasing prevalence of cardiovascular diseases and the growing aging population. As heart-related conditions become more common, the need for devices such as heart valves, pacemakers, and implantable defibrillators is growing. Additionally, the healthcare system across the region focuses on quality healthcare delivery and reimbursement support for medical devices also plays a significant role in the growth of the market. Moreover, research and development efforts aimed at developing innovative and minimally invasive prosthetic devices are significantly supporting the market.

On the contrary, Asia Pacific is estimated to expand further in this domain in the coming years due to the aging population and changing lifestyles. In confluence with this, advancements in healthcare infrastructure and the rising disposable income in several countries within the Asia Pacific region have improved access to medical treatments and increased affordability. Furthermore, ongoing technological advancements and innovations in the field are driving the market in Asia Pacific.

Competitive Landscape:

The market is experiencing significant growth due to the continual advancements in medical technology and surgical procedures leading to the development of innovative and more efficient devices. Additionally, the integration of digital health technologies is creating opportunities for companies to offer remote monitoring solutions and personalized healthcare services, enhancing patient outcomes and increasing the overall value proposition of their products. Also, numerous companies are developing tailored solutions to address specific patient needs, this is gaining prominence across the globe. Moreover, the development of 3D printing technology has further facilitated the production of patient-specific devices, allowing for better fit and improved functionality. Additionally, top companies are investing in research and development to create customizable solutions and collaborate with healthcare professionals to understand patient requirements, which is influencing the market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Biotronik
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology Co. Ltd.
  • Medtronic Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Siemens Healthcare GmbH
  • Sorin Group
  • St. Jude Medical Inc.

Key Questions Answered in This Report:

  • How has the global cardiac prosthetic devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global cardiac prosthetic devices market?
  • What is the impact of each driver, restraint, and opportunity on the global cardiac prosthetic devices market?
  • What are the key regional markets?
  • Which countries represent the most attractive cardiac prosthetic devices market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the cardiac prosthetic devices market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the cardiac prosthetic devices market?
  • What is the competitive structure of the global cardiac prosthetic devices market?
  • Who are the key players/companies in the global cardiac prosthetic devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac Prosthetic Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Valves
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Mechanical Valve
      • 6.1.2.2 Tissue Valve
      • 6.1.2.3 Stented Tissue Valve
      • 6.1.2.4 Stentless Tissue Valve
      • 6.1.2.5 Transcatheter Valve
    • 6.1.3 Market Forecast
  • 6.2 Pacemakers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Implantable Pacemakers
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Single-Chamber Battery Pacemaker
      • 6.3.2.2 Dual-Chamber Battery Pacemaker
      • 6.3.2.3 Triple-Chamber Battery Pacemaker
    • 6.3.3 Market Forecast
  • 6.4 External Pacemakers
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by End-User

  • 7.1 Hospitals, Clinics and Cardiac Centers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ambulatory Surgical Centers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Biotronik
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Boston Scientific Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Edwards Lifesciences Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Lepu Medical Technology Co. Ltd.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Medtronic Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Meril Life Sciences Pvt. Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Siemens Healthcare GmbH
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Sorin Group
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 St. Jude Medical Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Cardiac Prosthetic Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Prosthetic Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cardiac Prosthetic Devices Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: Cardiac Prosthetic Devices Market: Breakup by End-User (in %), 2024
  • Figure 5: Global: Cardiac Prosthetic Devices Market: Breakup by Region (in %), 2024
  • Figure 6: Global: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 7: Global: Cardiac Prosthetic Devices (Valves) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Cardiac Prosthetic Devices (Valves) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Cardiac Prosthetic Devices (Pacemakers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Cardiac Prosthetic Devices (Pacemakers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Cardiac Prosthetic Devices (Implantable Pacemakers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Cardiac Prosthetic Devices (Implantable Pacemakers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Cardiac Prosthetic Devices (External Pacemakers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Cardiac Prosthetic Devices (External Pacemakers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Cardiac Prosthetic Devices (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Cardiac Prosthetic Devices (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Cardiac Prosthetic Devices (Hospitals, Clinics and Cardiac Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Cardiac Prosthetic Devices (Hospitals, Clinics and Cardiac Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Cardiac Prosthetic Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Cardiac Prosthetic Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Cardiac Prosthetic Devices (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Cardiac Prosthetic Devices (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: North America: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: North America: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: United States: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: United States: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Canada: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Canada: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Asia Pacific: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Asia Pacific: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: China: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: China: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Japan: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Japan: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: India: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: India: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: South Korea: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: South Korea: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Australia: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Australia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Indonesia: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Indonesia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Europe: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Europe: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Germany: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Germany: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: France: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: France: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: United Kingdom: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: United Kingdom: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Italy: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Italy: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Spain: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Spain: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Russia: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Russia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Latin America: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Latin America: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Brazil: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Brazil: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Mexico: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Mexico: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Middle East and Africa: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Middle East and Africa: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Global: Cardiac Prosthetic Devices Industry: SWOT Analysis
  • Figure 72: Global: Cardiac Prosthetic Devices Industry: Value Chain Analysis
  • Figure 73: Global: Cardiac Prosthetic Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiac Prosthetic Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 4: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Cardiac Prosthetic Devices Market: Competitive Structure
  • Table 6: Global: Cardiac Prosthetic Devices Market: Key Players